• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Outcomes in patients with infections and augmented renal clearance: A multicenter retrospective study.伴有感染和增强肾清除率患者的结局:一项多中心回顾性研究。
PLoS One. 2018 Dec 10;13(12):e0208742. doi: 10.1371/journal.pone.0208742. eCollection 2018.
2
Augmented renal clearance in Japanese intensive care unit patients: a prospective study.日本重症监护病房患者的肾脏清除率增加:一项前瞻性研究。
J Intensive Care. 2016 Oct 3;4:62. doi: 10.1186/s40560-016-0187-7. eCollection 2016.
3
Risk Factors and Clinical Outcomes Associated With Augmented Renal Clearance in Trauma Patients.创伤患者增强肾清除率相关的风险因素和临床结果。
J Surg Res. 2019 Dec;244:477-483. doi: 10.1016/j.jss.2019.06.087. Epub 2019 Jul 19.
4
Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy.增强型肾清除率是接受抗菌治疗的危重症患者的常见现象,与更差的临床结局相关。
J Crit Care. 2013 Oct;28(5):695-700. doi: 10.1016/j.jcrc.2013.03.003. Epub 2013 May 14.
5
Identifying augmented renal clearance in trauma patients: Validation of the Augmented Renal Clearance in Trauma Intensive Care scoring system.识别创伤患者的肾脏清除率增加:创伤重症监护中肾脏清除率增加评分系统的验证
J Trauma Acute Care Surg. 2017 Apr;82(4):665-671. doi: 10.1097/TA.0000000000001387.
6
Augmented renal clearance in critically ill patients with cancer (ARCCAN Study): A prospective observational study evaluating prevalence and risk factors.癌症危重症患者的增强肾清除率(ARCCAN 研究):一项前瞻性观察研究,评估其患病率和危险因素。
Pharmacol Res Perspect. 2021 Apr;9(2):e00747. doi: 10.1002/prp2.747.
7
Prevalence and Risk Factors for Augmented Renal Clearance in a Population of Critically Ill Patients.危重症患者群体中增强型肾脏清除率的流行情况及危险因素。
J Intensive Care Med. 2020 Oct;35(10):1044-1052. doi: 10.1177/0885066618809688. Epub 2018 Oct 29.
8
Augmented renal clearance--an evolving risk factor to consider during the treatment with vancomycin.增强的肾功能清除率--在万古霉素治疗期间需要考虑的一个不断变化的风险因素。
J Clin Pharm Ther. 2013 Dec;38(6):462-7. doi: 10.1111/jcpt.12088. Epub 2013 Aug 8.
9
Association of Urinary Neutrophil Gelatinase-Associated Lipocalin With Long-Term Renal Outcomes in ICU Survivors: A Retrospective Observational Cohort Study.重症监护病房幸存者中尿中性粒细胞明胶酶相关脂质运载蛋白与长期肾脏结局的关联:一项回顾性观察队列研究
Shock. 2016 Jul;46(1):44-51. doi: 10.1097/SHK.0000000000000580.
10
Prevalence of augmented renal clearance and performance of glomerular filtration estimates in Indigenous Australian patients requiring intensive care admission.澳大利亚原住民重症监护入院患者中肾脏清除率增加的患病率及肾小球滤过率估计值的表现。
Anaesth Intensive Care. 2018 Jan;46(1):42-50. doi: 10.1177/0310057X1804600107.

引用本文的文献

1
Machine learning for the prediction of augmented renal clearance (ARC) in patients with sepsis in critical care units.用于预测重症监护病房脓毒症患者肾脏清除率增加(ARC)的机器学习
Sci Rep. 2025 Jul 18;15(1):26119. doi: 10.1038/s41598-025-11313-2.
2
Renal resistive index for the prediction of augmented renal clearance: a prospective observational study.肾阻力指数预测肾脏清除率增加:一项前瞻性观察研究。
J Ultrasound. 2025 Jun 23. doi: 10.1007/s40477-025-01035-6.
3
Clinical characteristics and early identification of augmented renal clearance in PICU patients with severe sepsis associated with MRSA infection.重症监护病房中耐甲氧西林金黄色葡萄球菌感染所致严重脓毒症患儿肾脏高滤过的临床特征及早期识别
Front Pediatr. 2024 Nov 25;12:1433417. doi: 10.3389/fped.2024.1433417. eCollection 2024.
4
Development and validation of the prediction score for augmented renal clearance in critically Ill Japanese adults.危重症日本成年人强化肾清除率预测评分的开发与验证
J Pharm Health Care Sci. 2024 Nov 6;10(1):69. doi: 10.1186/s40780-024-00394-2.
5
Relationship of imipenem therapeutic drug monitoring to clinical outcomes in critically ill patients: a retrospective cohort study.重症患者中亚胺培南治疗药物监测与临床结局的关系:一项回顾性队列研究。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):4791-4798. doi: 10.1007/s00210-023-02909-4. Epub 2023 Dec 28.
6
Clinical implications of augmented renal clearance after unrelated single cord blood transplantation in adults.成人无关单份脐带血移植后增强的肾清除率的临床意义。
Int J Hematol. 2023 Dec;118(6):718-725. doi: 10.1007/s12185-023-03669-w. Epub 2023 Oct 18.
7
External Validation of the Augmented Renal Clearance Predictor in Critically Ill COVID-19 Patients.重症 COVID-19 患者中增强肾清除率预测指标的外部验证
Antibiotics (Basel). 2023 Apr 3;12(4):698. doi: 10.3390/antibiotics12040698.
8
Onset timing and duration of augmented renal clearance in a mixed intensive care unit.混合重症监护病房中肾脏清除率增加的起始时间和持续时间。
J Intensive Care. 2023 Mar 23;11(1):13. doi: 10.1186/s40560-023-00660-9.
9
Augmented renal clearance in the ICU: estimation, incidence, risk factors and consequences-a retrospective observational study.重症监护病房中的肾脏清除率增加:评估、发生率、危险因素及后果——一项回顾性观察研究
Ann Intensive Care. 2022 Sep 26;12(1):88. doi: 10.1186/s13613-022-01058-w.
10
Risk factors associated with augmented renal clearance in a mixed intensive care unit population: a retrospective study.在混合重症监护病房人群中与增强肾清除率相关的风险因素:一项回顾性研究。
Int J Clin Pharm. 2022 Dec;44(6):1277-1286. doi: 10.1007/s11096-022-01458-9. Epub 2022 Jul 14.

本文引用的文献

1
Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study.连续输注大剂量β-内酰胺类药物治疗危重症脓毒症患者时,肾清除增强、抗生素暴露与临床结局的相关性:一项前瞻性观察研究。
Int J Antimicrob Agents. 2018 Mar;51(3):443-449. doi: 10.1016/j.ijantimicag.2017.11.013. Epub 2017 Nov 24.
2
Augmented Renal Clearance in Critical Illness: An Important Consideration in Drug Dosing.危重症患者的肾脏清除率增加:药物剂量计算中的一个重要考量因素
Pharmaceutics. 2017 Sep 16;9(3):36. doi: 10.3390/pharmaceutics9030036.
3
Association between augmented renal clearance and clinical failure of antibiotic treatment in brain-injured patients with ventilator-acquired pneumonia: A preliminary study.颅脑损伤合并呼吸机相关性肺炎患者肾清除率增高与抗生素治疗临床失败的相关性:一项初步研究。
Anaesth Crit Care Pain Med. 2018 Feb;37(1):35-41. doi: 10.1016/j.accpm.2017.06.006. Epub 2017 Jul 26.
4
Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials.在接受适当经验性抗菌药物治疗的肠杆菌科血流感染中,肾脏清除率增加并非死亡的危险因素。
PLoS One. 2017 Jul 5;12(7):e0180247. doi: 10.1371/journal.pone.0180247. eCollection 2017.
5
Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial.连续或间断输注β-内酰胺类抗生素治疗患者中增强的肾清除率与临床结局的关系:BLING-II 随机、安慰剂对照临床试验的嵌套队列研究。
Int J Antimicrob Agents. 2017 May;49(5):624-630. doi: 10.1016/j.ijantimicag.2016.12.022. Epub 2017 Mar 9.
6
Identifying augmented renal clearance in trauma patients: Validation of the Augmented Renal Clearance in Trauma Intensive Care scoring system.识别创伤患者的肾脏清除率增加:创伤重症监护中肾脏清除率增加评分系统的验证
J Trauma Acute Care Surg. 2017 Apr;82(4):665-671. doi: 10.1097/TA.0000000000001387.
7
Augmented renal clearance in Japanese intensive care unit patients: a prospective study.日本重症监护病房患者的肾脏清除率增加:一项前瞻性研究。
J Intensive Care. 2016 Oct 3;4:62. doi: 10.1186/s40560-016-0187-7. eCollection 2016.
8
Application of vancomycin in patients with varying renal function, especially those with augmented renal clearance.万古霉素在不同肾功能患者中的应用,尤其是那些肾脏清除率增加的患者。
Pharm Biol. 2016 Dec;54(12):2802-2806. doi: 10.1080/13880209.2016.1183684. Epub 2016 Jun 1.
9
Augmented Renal Clearance in Pediatric Patients With Febrile Neutropenia Associated With Vancomycin Clearance.发热性中性粒细胞减少症患儿的肾脏清除率增加与万古霉素清除率相关。
Ther Drug Monit. 2016 Jun;38(3):393-7. doi: 10.1097/FTD.0000000000000270.
10
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).《脓毒症及脓毒性休克第三次国际共识定义(脓毒症-3)》
JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.

伴有感染和增强肾清除率患者的结局:一项多中心回顾性研究。

Outcomes in patients with infections and augmented renal clearance: A multicenter retrospective study.

机构信息

Department of Emergency and Critical Care Medicine, Fukuoka University Hospital, Fukuoka, Japan.

Department of Emergency and Critical Care Center, Kochi Health Sciences Center, Kochi, Japan.

出版信息

PLoS One. 2018 Dec 10;13(12):e0208742. doi: 10.1371/journal.pone.0208742. eCollection 2018.

DOI:10.1371/journal.pone.0208742
PMID:30532142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6287846/
Abstract

Recently, augmented renal clearance (ARC), which accelerates glomerular filtration of renally eliminated drugs thereby reducing the systemic exposure to these drugs, has started to receive attention. However, the clinical features associated with ARC are still not well understood, especially in the Japanese population. This study aimed to evaluate the clinical characteristics and outcomes of ARC patients with infections in Japanese intensive care unit (ICU) settings. We conducted a retrospective observational study from April 2013 to May 2017 at two tertiary level ICUs in Japan, which included 280 patients with infections (median age 74 years; interquartile range, 64-83 years). We evaluated the estimated glomerular filtration rate (eGFR) at ICU admission using the Japanese equation, and ARC was defined as eGFR >130 mL/min/1.73 m2. Multivariable logistic regression analysis was performed to identify the independent risk factors for ARC and to determine if it was a predictor of ICU mortality. In addition, a receiver operating curve (ROC) analysis was performed, and the area under the ROC (AUROC) was determined to examine the significant variables that predict ARC. In total, 19 patients (6.8%) manifested ARC. Multivariable logistic regression analysis identified younger age as an independent risk factor for ARC (odds ratio [OR], 0.94; 95% confidence interval [CI], 0.91-0.96). However, ARC was not found to be a predictor of ICU mortality (OR, 0.57; 95% CI, 0.11-2.92). In addition, the AUROC of age was 0.79 (95% CI, 0.68-0.91), and the optimal cut off age for ARC was ≤63 years (sensitivity, 68.4%; specificity, 78.9%). The incidence of ARC was, therefore, low among patients with infections in the Japanese ICUs. Although younger age was associated with the incidence of ARC, it was not an independent predictor of ICU mortality.

摘要

最近,加速肾脏清除率(ARC)引起了人们的关注,ARC 可加速经肾脏排泄的药物的肾小球滤过,从而降低这些药物的全身暴露。然而,与 ARC 相关的临床特征仍未被很好地理解,特别是在日本人群中。本研究旨在评估日本重症监护病房(ICU)中感染合并 ARC 患者的临床特征和结局。我们进行了一项回顾性观察性研究,纳入了 2013 年 4 月至 2017 年 5 月日本两家三级医院 ICU 中 280 例感染患者(中位年龄 74 岁;四分位间距 64-83 岁)。我们使用日本方程评估 ICU 入院时的估算肾小球滤过率(eGFR),并将 eGFR>130 mL/min/1.73 m2 定义为 ARC。采用多变量 logistic 回归分析确定 ARC 的独立危险因素,并确定其是否为 ICU 死亡率的预测因素。此外,我们还进行了受试者工作特征曲线(ROC)分析,并确定了预测 ARC 的显著变量的 ROC 曲线下面积(AUROC)。共有 19 例(6.8%)患者表现为 ARC。多变量 logistic 回归分析发现年龄较小是 ARC 的独立危险因素(比值比 [OR],0.94;95%置信区间 [CI],0.91-0.96)。然而,ARC 并非 ICU 死亡率的预测因素(OR,0.57;95% CI,0.11-2.92)。此外,年龄的 AUROC 为 0.79(95% CI,0.68-0.91),ARC 的最佳截断年龄为≤63 岁(灵敏度,68.4%;特异性,78.9%)。因此,日本 ICU 中感染患者的 ARC 发生率较低。尽管年龄较小与 ARC 的发生有关,但它不是 ICU 死亡率的独立预测因素。